Virtus AllianzGI Dividend Interest & Premium Strategy Fund Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison

Buy

58

NFJ
Virtus AllianzGI Dividend Interest & Premium Strategy Fund

Last Price:

$12.91

Seasonality Move:

0.43%

Sell

43

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:

$397.25

Seasonality Move:

0.84%

Buy

58

Virtus AllianzGI Dividend Interest & Premium Strategy Fund (NFJ) is a Buy

Is Virtus AllianzGI Dividend Interest & Premium Strategy Fund a Buy, Sell or Hold?

The current Virtus AllianzGI Dividend Interest & Premium Strategy Fund [NFJ] share price is $12.90. The Score for NFJ is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
NFJ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

43

Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?

The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $398.82. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NFJ Stock Price Chart

What is Virtus AllianzGI Dividend Interest & Premium Strategy Fund's stock price today?

The Virtus AllianzGI Dividend Interest & Premium Strategy Fund share price today is $12.90

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NFJ is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals, Inc.'s stock price today?

The Alnylam Pharmaceuticals, Inc. share price today is $398.82

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

NFJ Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.01	Sell
Relative Strength Index (14 RSI):	51.39	Buy
Chaikin Money Flow:	168238	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(12.67 - 13.09)	Buy
Bollinger Bands (100):	(12.72 - 13.06)	Buy

ALNY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-13.02	Sell
Relative Strength Index (14 RSI):	38.18	Sell
Chaikin Money Flow:	-239813	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(395.38 - 448.66)	Sell
Bollinger Bands (100):	(424.51 - 470.03)	Sell

NFJ Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	12.79	Buy
20-day SMA:	12.94	Sell
50-day SMA:	12.87	Buy
200-day SMA:	12.47	Buy
8-day EMA:	12.86	Buy
20-day EMA:	12.87	Buy
50-day EMA:	12.87	Buy
200-day EMA:	12.69	Buy

ALNY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	399.36	Sell
20-day SMA:	417.68	Sell
50-day SMA:	439.71	Sell
200-day SMA:	369.63	Buy
8-day EMA:	401.33	Sell
20-day EMA:	412.78	Sell
50-day EMA:	428.62	Sell
200-day EMA:	383.63	Buy

Virtus AllianzGI Dividend Interest & Premium Strategy Fund Earnings Growth & NFJ Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates

Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and a decrease next year of $0.00 per share.

Virtus AllianzGI Dividend Interest & Premium Strategy Fund Technical Analysis

	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 24	Dec 26	Dec 29
	Dec
	12	15	16	17	18	19	22	24	26	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals, Inc. Technical Analysis

	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23	Dec 24	Dec 26	Dec 29
	Dec
	15	16	17	18	19	22	23	24	26	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):